pharmaphorum June 14, 2023
A new US start-up, STAT Health, has emerged from the shadows with $5.1 million in funding to develop an in-ear wearable device that can measure blood flow in the brain, which it says is the “missing vital sign”.
According to the company, the earbud-like device could help researchers get to the bottom of complex and poorly understood health conditions like long COVID, postural orthostatic tachycardia syndrome (POTS), and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
What these disorders have in common are symptoms such as dizziness, brain fog, headaches, fainting, and fatigue, that can get worse when the patient stands up and are all thought to be associated with reduced cerebral blood flow (CBF).
That can be measured using ultrasound technology, but...